Healthcare-only scale vs. a published fintech-and-healthcare rate
A patient trying to reschedule an appointment before an EHR-synced deadline is exactly the workflow Hyro was built around, patient access at hospital scale. Fini takes a broader path, one platform spanning both fintech and healthcare, with a published rate. Both are healthcare-serious companies, but only one publishes its price.
In this comparison: What each is · How they differ · Capabilities · Feature by feature · Ease of use · What customers say · The full side-by-side · Which to choose · Compliance · FAQ
What is Fini?
Fini is an AI customer-support agent priced per resolution, backed by Y Combinator and Matrix Partners. It connects natively to your helpdesk, knowledge base, CRM, billing, claims, and EHR systems, reaches a 90% resolution rate at 99% accuracy, and is built to be live in 14 days and fully autonomous in 30. Across its customer base, Fini handles more than 3 million monthly resolutions in fintech and healthcare. The agent works across voice, chat, and email, answers in 130+ languages, and returns a first response in about five seconds.
Pricing starts at $0.49 per resolution, with no per-seat fees, so a team can model its own cost from ticket volume alone, before a sales conversation ever starts.
What is Hyro?
Hyro is a New York-based AI agent platform for healthcare, founded in 2018 by Israel Krush (CEO) and Rom Cohen (CIO), originally operating under the name Airbud before rebranding. The company has raised $95 million to date, including a $10.5 million Series A in 2021 led by Spero Ventures with Twilio participating, and a $45 million strategic growth round in October 2025 led by Healthier Capital, with ServiceNow Ventures and health system Bon Secours Mercy Health also investing. It is not Y Combinator or Matrix Partners backed.
Hyro describes itself as an "Agentic Care Communications Platform" built exclusively for health systems, running on a hybrid architecture it calls ACE, combining large language models with proprietary small language models and healthcare-specific knowledge graphs. The company states its agents are deployed across more than 2,500 health system facilities, including Intermountain Health, Sutter Health, Tampa General Hospital, and Hartford Healthcare, resolving up to 85% of routine patient interactions.
Hyro pricing in 2026
Hyro does not publish pricing anywhere on its site. No pricing page, price list, or tiered-plan structure was located through direct site access or press releases; the company's enterprise, health-system-only sales motion is consistent with quote-based pricing disclosed only through direct sales contact.
Fini publishes its rate directly: $0.49 per resolution, starting rate, with no per-seat fees and no separate platform charge. A Hyro buyer has to enter a direct sales process before learning any number at all. A Fini buyer can model the exact cost of their next 1,000 resolutions from the published rate alone.
What buyers ask | Hyro | Fini |
|---|---|---|
Published price list | ✗ | ✓ |
Price | Not published, quoted per health system | $0.49 per resolution |
Free trial or self-serve | None, enterprise sales only | Not self-serve, staged onboarding team instead |
Vertical served | Healthcare only | Fintech and healthcare |
Can you model cost before a sales call? | No | Yes |
See Fini's full pricing breakdown for plan details, add-ons, and a resolution calculator.
How Fini and Hyro differ
Fini's $0.49 per resolution is visible before a sales call; Hyro publishes no pricing information at all, anywhere on its site. Hyro's current product and every named customer are healthcare-exclusive, while Fini splits its focus across fintech and healthcare, with native connections into billing and claims systems that a healthcare-only platform has no reason to build.
The two companies also differ on investor overlap and go-live speed. Hyro's October 2025 funding round includes Bon Secours Mercy Health and ServiceNow Ventures as investors, both of which are also named commercial partners or customers, a pattern worth being aware of when weighing customer validation, and it claims complex voice solutions deploy in under 100 days on average. Fini's Y Combinator and Matrix Partners backing does not overlap with its named customer list, and it publishes a fixed staged rollout (live in 14 days, fully autonomous in 30) regardless of starting resolution rate.
Capabilities side by side
Both platforms genuinely execute transactions rather than only answering questions. Hyro's ACE engine maps conversations across more than 1,000 distinct patient intents, and its June 2026 Care Intelligence launch turns AI agent conversation data into operational signals for hospital administrators, with deep EHR integration, including Epic, cited by Hyro's own commissioned benchmark study as the single biggest driver of ROI. Fini connects natively across helpdesk, CRM, billing, claims, and EHR systems in one connector set, and adds voice as a native channel alongside chat and email.
Hyro has built specific technology partnerships with Five9 for contact-center integration and ServiceNow for workflow automation, both aimed at reducing integration friction for large health systems. Fini publishes its compliance posture as a fixed certification list rather than a named partner integration roster, covered in the Compliance section below.
Feature by feature
Feature | Fini | Hyro |
|---|---|---|
Channels | Voice, chat, email | Voice, chat, SMS, mobile app |
Languages | 130+, published | Not published |
Fintech workflows (billing) | ✓, native | ✗, healthcare-only focus |
Conversation-to-operations analytics | Not a published product line | ✓ (Care Intelligence) |
Published outcome guarantee | ✓ (90-Day Money-Back Guarantee) | None published |
Published pricing | ✓ | ✗ |
Ease of use and admin experience
Hyro claims complex voice solutions deploy in under 100 days on average, a self-reported figure rather than an independently audited standard. Fini's published staged rollout (live in 14 days, fully autonomous in 30) is run by a dedicated onboarding team against a fixed timeline.
No G2 or Capterra listing could be located for Hyro at the time of this research, on either platform, so independent, crowd-sourced review data was not available. This should be treated as a research-session limitation rather than confirmed proof that no reviews exist; buyers should check both platforms directly.
Fini's differentiators
Published, forecastable pricing
a starting rate of $0.49 per resolution, visible before any sales call, versus Hyro's undisclosed rate.
Fintech and healthcare, not healthcare alone
Native connections into billing and claims systems cover a second regulated vertical Hyro does not serve.
A fixed, staged rollout: live in 14 days, fully autonomous in 30
A specific, published timeline instead of Hyro's self-reported "under 100 days" average.
A published outcome guarantee
The 90-Day Money-Back Guarantee ties payment to an 90% resolution rate within 90 days, at a publicly quoted rate.
Hyro's recognized strengths
Hyro earns real credit on specific, well-sourced points. Its $95 million in funding includes strategic capital from Twilio and ServiceNow Ventures, both companies whose infrastructure Hyro also integrates with commercially, a genuine alignment between investor and product relationships. Hyro commissioned an independently fielded survey of 387 healthcare directors and above, run by research firm Global Surveyz, finding an average annual ROI of $586,000 and that deep EHR integration specifically drove dramatically higher returns, a more rigorous data source than a typical vendor case study, even though Hyro funded and published the study itself. Its named customer list, Intermountain Health, Sutter Health, Hartford Healthcare, spans real, well-known US health systems.
What customers say
No G2 or Capterra listing could be located for Hyro at the time of this research, so independent, crowd-sourced feedback was not available. Hyro's own press releases report that customers achieved a 35% decrease in operational costs and a fivefold return on investment, and named customer quotes from Tampa General Hospital and Hartford Healthcare cite reduced wait times and better visibility into patient access operations. Hyro's own commissioned benchmark study, while independently fielded by a third-party research firm, was funded and published by Hyro itself, so these figures should be read as company-sponsored data rather than a fully arm's-length audit.
The full side-by-side
Fini | Hyro | |
|---|---|---|
Pricing | $0.49 per resolution, starting rate | Not published |
Outcome guarantee | 90-Day Money-Back Guarantee, 90% in 90 days | None published |
Go-live | Live in 14 days, fully autonomous in 30 | "Under 100 days," self-reported average |
Channels | Voice, chat, email | Voice, chat, SMS, mobile app |
Vertical scope | Fintech and healthcare | Healthcare only |
Compliance | SOC 2 Type II, ISO 27001, GDPR, HIPAA-BAA-eligible, CCPA under agreement | States HIPAA-compliant; SOC 2 and HITRUST status not independently confirmed |
Backing | Y Combinator, Matrix Partners | $95M raised (Healthier Capital, Twilio, ServiceNow Ventures) |
Named customers | 3M+ monthly resolutions across fintech and healthcare | 2,500+ facilities including Intermountain Health, Sutter Health |
Which should you choose?
Choose Fini if you want a published, flat per-resolution rate you can model before a sales call, a confirmed compliance certification list, and coverage across both fintech and healthcare workflows including billing and claims. Choose Hyro if you are a large hospital or health system specifically and want a platform with deep EHR-integration benchmarking data and dedicated Five9 and ServiceNow partnerships.
A useful gut check: if your organization needs fintech workflows alongside healthcare ones, or wants to see the exact per-resolution rate and a documented certification list before a scoped sales conversation, Fini's published pricing and compliance list are built for exactly that situation. If you're a hospital or health system exclusively and want deep patient-access analytics layered on top of your existing EHR, Hyro's healthcare-only focus is the more relevant comparison. See how Fini also compares against Ushur and Glia, two other regulated-industry platforms in this category.
Compliance
Fini publishes SOC 2 Type II, ISO 27001, GDPR compliance, HIPAA-compliant BAA-eligible contracting, and CCPA availability under agreement, all listed together in one place. Hyro's own site describes its platform generically as a "HIPAA-compliant solution," but no independently verifiable SOC 2, HITRUST, or GDPR certification could be confirmed for Hyro in this research, its dedicated security or trust page could not be directly accessed.
Given Hyro serves major US health systems, it is plausible additional certifications exist behind an NDA or a gated trust center, but nothing public currently confirms this. Buyers with a hard SOC 2 or HITRUST requirement should request Hyro's current compliance documentation directly rather than relying on general homepage language.
Ready to compare on your own data?
The fastest way to know which platform actually fits your ticket volume and compliance requirements is to run the numbers against your own data rather than a vendor's published averages. See Fini's plans or talk to the team about a side-by-side pilot. If you're also weighing another healthcare-focused platform, our Ushur vs Fini comparison covers a similarly regulated, HITRUST-certified alternative, and our explainer on KYC automation covers how onboarding-checks workflows work across this category.
Is Hyro's pricing public?
No. Hyro does not publish pricing anywhere on its site, and its enterprise, health-system-only sales motion routes prospects to direct sales instead. Fini publishes its rate directly: $0.49 per resolution, starting rate.
Who founded Hyro and when?
Hyro was founded in 2018 by Israel Krush (CEO) and Rom Cohen (CIO), originally operating under the name Airbud. The company is headquartered in New York.
How much has Hyro raised?
Hyro has raised $95 million to date, including a $10.5 million Series A in 2021 led by Spero Ventures with Twilio participating, and a $45 million strategic growth round in October 2025 led by Healthier Capital, with ServiceNow Ventures and Bon Secours Mercy Health also investing. It is not Y Combinator or Matrix Partners backed.
Does Hyro serve fintech companies?
No. Hyro's current product and every named customer are healthcare-exclusive. Fini serves both fintech and healthcare, with native connections into billing and claims systems.
How fast can each platform go live?
Fini publishes a staged rollout: live in 14 days, fully autonomous in 30. Hyro claims complex voice solutions deploy in under 100 days on average, a self-reported figure rather than a guaranteed timeline.
What is Hyro's Care Intelligence product?
Launched in June 2026, Care Intelligence is Hyro's analytics layer that converts AI agent conversation data into operational insight for health systems, benchmarked against a claimed 100 million patient interactions across more than 2,500 facilities, per Hyro's own announcement.
Is Hyro SOC 2 or HITRUST certified?
Hyro's site describes its platform generically as HIPAA-compliant, but no independently verifiable SOC 2, HITRUST, or GDPR certification could be confirmed in this research. Fini publishes SOC 2 Type II, ISO 27001, GDPR, HIPAA-BAA-eligible contracting, and CCPA together.
Does Fini offer any guarantee Hyro doesn't?
Fini's 90-Day Money-Back Guarantee ties payment to results, an 90% resolution rate within 90 days, at a publicly quoted rate. No equivalent outcome guarantee was found published on Hyro's site.
Who are Hyro's named customers?
Intermountain Health, Sutter Health, Tampa General Hospital, Hartford Healthcare, and Bon Secours Mercy Health are among the health systems named in Hyro's own press releases, out of more than 2,500 facilities it says it serves.
Does Hyro have independent reviews on G2 or Capterra?
No G2 or Capterra listing could be located for Hyro at the time of this research on either platform, so independent, crowd-sourced review data is not currently available.
